TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
AUTL

Autolus Therapeutics plc

Healthcare · Biotechnology

1.90$ -2.9% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Autolus Therapeutics plc (AUTL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 76 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement AUTL
Line item 2015 2016 2017 2018 2018 2019 2020 2021 2022 2023 2024 2025
0.1 1.2 1.7 1.0 1.0 2.9 1.7 1.5 6.2 1.7 10 76
0.0 0.5 1.0 48 48 105 135 129 137 6.6 141 97
0.1 0.7 0.7 -47 -47 -103 -133 1.5 6.2 1.7 -131 -21
2.2 10 16 25 25 106 135 111 117 130 158 129
6.0 5.2 9.1 17 17 39 35 32 32 47 101 132
8.2 16 25 41 41 145 170 142 149 181 111 260
-8.1 -14 -23 -58 -58 -248 -303 -140 -143 -180 -241 -281
0.0 0.0 0.0 0.0 0.0 1.1 1.9 1.1 8.9 45 9.3 37
-8.1 -14 -23 -36 -36 -109 -166 -142 -149 -208 -219 -297
-0.6 -1.8 -3.7 -5.2 -5.2 15 -24 0.1 0.3 0.0 1.5 -8.6
-7.5 -13 -20 -31 -31 -124 -142 -142 -149 -208 -221 -288
-4.5 -14 -22 -35 -50 -137 -163 -132 -132 -157 -233 -250

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?